Skip to main content

Post-Approval Compliance Monitoring (PACM)

Post-Approval Compliance Monitoring (PACM) is part of Florida State University's Office for Human Subjects Protection (OHSP) and the IRB's ongoing oversight of approved human subjects research. PACM supports study teams throughout the life of a study by providing structured monitoring activities that help ensure compliance with IRB-approved protocols and applicable regulatory and institutional requirements. 


PACM consists of two complementary components: PACM Oversight, the core study monitoring function, and PACM Engagement and Check-Ins, a supportive layer that provides education, communication, and ongoing compliance support. Together, these activities provide both formal oversight and collaborative support throughout the conduct of a study. 

PACM Overview

 

PACM Activities

PACM activities include routine monitoring and targeted reviews. Most PACM activities are routine and do not indicate a concern with a study. Certain activities, such as For-Cause Reviews, are initiated in response to specific concerns or reported events that warrant additional review.

Standard Review

  • Purpose: Routine oversight of approved expedited and full board studies
  • Basis for Review: Planned (random, risk/complexity informed per PACM selection criteria)
  • Engagement Model: Collaborative OHSP & Study Team
  • Study Team Involvement: Active engagement based on scope
  • Scope: Study activities (consent, recruitment procedures, data management etc); may be focused or comprehensive 

Review Level Alignment

  • Purpose: Confirmation of alignment of the IRB review level with the current study activities
  • Basis for Review: Planned (random, risk/complexity informed per PACM selection criteria)
  • Engagement Model: OHSP-directed structured response
  • Study Team Involvement: Clarification; brief response/insight
  • Scope: IRB review classification and current study conduct 

For-Cause Review

  • Purpose: Investigation of potential or reported non-compliance or harm to participants
  • Basis for Review: Triggered (complaints, deviations, external reports, or concerns)
  • Engagement Model: Collaborative OHSP & Study Team
  • Study Team Involvement: Active engagement
  • Scope: Specific issues or areas of concern; may expand in scope depending on findings or emerging information 

 

Exempt Check-In

  • Purpose: Brief touchpoint of exempt studies on progress and ethical practices
  • Basis for Review: Planned (random, risk/complexity informed per PACM selection criteria)
  • Engagement Model: OHSP-directed structured response
  • Study Team Involvement: Brief informational response via checklist
  • Scope: Exempt study status and progress updates; may be brief or expanded based on study updates or input by PI 

 Training Check-In 

  • Purpose: Verification of training and role compliance
  • Basis for Review: Planned (random)
  • Engagement Model: OHSP-directed structured response
  • Study Team Involvement: Brief informational response via checklist
  • Scope: CITI training status and role assignments of study personnel; may included PI-identified training gaps 

Self-Assessment 

  • Purpose: PI-led review of study compliance and PACM tools
  • Basis for Review: Voluntary (PI-initiated with PACM support requested)
  • Engagement Model: Study team-led engagement
  • Study Team Involvement: Owned by study team; optional worksheet
  • Scope: Study activities as determined by PI using PACM tools; may be submitted for feedback or support 

PACM Process and Expectations

The PACM process varies depending on type and purpose of the activity. Study teams may be asked to provide study records, respond to questions, or participant in discussions and/or structured interviews with OHSP. PACM activities are intended to support compliance, identify areas for improvement, and promote ongoing adherence to IRB and institutional requirements. 

PACM activities are selected using defined selection criteria applied through two mechanisms: (1) risk/complexity-informed random sampling conducted at defined intervals, and (2) event-driven triggers, such as reported concerns, protocol deviations, external inquiries, or requests from the Principal Investigator.


Together, these approaches support broad and equitable oversight across the research portfolio while allowing for proactive, targeted review based on study complexity, participant risk, and evolving conditions. Selection criteria are designed to minimize burden on Principal Investigators, generally avoiding review of multiple studies under the same Principal Investigator within a 12-month period unless warranted by specific circumstances, such as new information or elevated risk.

PACM activities vary in the level and type of engagement between OHSP and the study team. Some activities are OHSP-directed with study team support, others are collaborative in nature with active participation from both OHSP and study team, and some are PI-led with OHSP involvement available as needed. Across all activities, engagement is designed to be proportionate to the scope and purpose of the review or check-in, and processes are designed to be transparent, clearly communicated, and minimally disruptive to ongoing research.

 

While specific steps vary by activity type, the general process follows a consistent structure:

  • Notification of selection or initiation of a PACM activity, including the type of activity and study or protocol(s) involved
  • Clear instructions on what to prepare or provide, including any applicable checklists, documentation requests, or response forms
  • Defined timelines for response and review, which vary based on the type of PACM activity
  • Ongoing communication throughout the process, including clarification requests or check-ins as needed
  • A summary of findings or outcome, which may include confirmation of compliance, recommendations, or required follow-up actions
  • When follow-up is required, the PI works with OHSP to address identified findings and complete any required corrective actions, which may include development of a Corrective and Preventive Action (CAPA) plan or other actions as appropriate
  • Findings and follow-up actions may be shared with the IRB and other institutional offices as appropriate, particularly when required for reporting, oversight, or review of elevated concerns.

PACM outcomes are intended to support research teams in maintaining compliance, strengthening study practices, and addressing any issues that require follow-up. Outcomes vary based on the type of PACM activity, the scope of the review, and observations identified. Multiple outcomes may apply within a single PACM activity, depending on the circumstances.

Review Outcomes

  • No findings
    Study activities and documentation align with the IRB-approved protocol and applicable requirements. No further action is needed.
  • Recommendations and best practices
    Minor opportunities for improvement are identified (e.g., documentation updates or process clarifications). Recommendations are shared with the research team; a formal response is not typically required.
  • Minor findings
    Limited deficiencies are identified that require correction. The PI provides a response outlining the planned corrective actions and timeline for resolution, as applicable. OHSP may provide guidance as needed and verifies that corrective actions are implemented.
  • Reportable findings
    More significant concerns may require formal reporting to the IRB. The PI submits a Reportable New Information (RNI) submission in RAMP IRB. The IRB review process of the RNI determines required corrective actions and next steps.


Follow-Up Actions

  • Follow-up or continued monitoring
    In some cases, additional engagement or monitoring may be conducted to support resolution of findings or to confirm sustained compliance.
  • Corrective Action Plan Required
  • Referral to other offices (if applicable)
    If identified concerns fall outside the scope of PACM oversight (e.g., research integrity, misconduct, or biosafety), OHSP coordinates with the appropriate institutional offices.

 

  PACM Support and Resources

 

Post-Approval Consultation

Have questions about post-approval responsibilities, study documentation, protocol changes, or preparing for a PACM review? Request a consultation with the Post-Approval Compliance Specialist for guidance, resources, and support to help maintain compliance throughout the life of your study.

Schedule a Consult 


Quality Assurance and Program Integrity

In addition to PACM study-level monitoring activities, periodic quality assurance activities are conducted to support the integrity and consistency of OHSP/IRB operations. These activities may include review of IRB meeting minutes, assessment of determination consistency, evaluation of documentation completeness, and review of IRB workflow performance metrics. These activities are system-level in nature, are not part of study monitoring, and do not involve direct engagement with study teams unless follow-up is required to address identified issues.